Eastern Caribbean Cruise & SeminarMarch 7 - 14, 2010Psychopharmacology: Drug Interactions, Pharmacogenomics and Evidence Based MedicineEarn Up To 15 hours of Continuing Education Credit |
|||
 |
|
|
|
  |
|||
Session 1B: Evidence Based Medicine: Best Practices in Dual Diagnosis, Substance Use Disorders including Alcohol, Opiates and Nicotine |
||||
|
||||
At the conclusion of this presentation, the participant should be able to: (1) Identify signs and symptoms of acute withdrawal, acute intoxication, and chronic dependency associated with alcohol, opiates, and nicotine. (2) Describe the pharmacologic and pharmacokinetic properties for pharmacotherapy used in the treatment of substance use disorder. (3) Apply evidence-based strategies for selecting appropriate pharmacotherapy for a patient with substance use disorder. (4) Develop a monitoring plan that includes assessment of efficacy, adverse effects, drug interactions, and toxicity.
|
||||
